Resources

The Australian Advantage

Why do CDMO’s in Europe, Asia and the US look to Australia for early stage…

Ryan HardingFebruary 27, 2026

News

First patient treated in PLATYPS ‘in-house’ CAR T-cell therapy trial

Melbourne, Australia The first clinical dose of PMCC-COE19, developed by Peter Mac and manufactured by…

Ryan HardingFebruary 20, 2026

News

Arovella IND Acceptance for iNKT Cell Therapy Platform

Melbourne, Australia Our client Arovella Therapeutics Ltd (ASX: ALA) recently announced that the U.S. Food…

Ryan HardingFebruary 18, 2026

News

ACTRIS Signs MoU with Cell Therapies Pty Ltd to Advance CDMO Capabilities for Cell and Gene Therapies

Cell Therapies CEO Bev Menner and ACTRIS Executive Director, A/Prof Aloysius Ho, at Cell Therapies'…

Ryan HardingFebruary 11, 2026

News

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing

Cell Therapies CEO Bev Menner and ENCell Director, CDMO Business Development Gonson Yeom at Cell…

Ryan HardingDecember 5, 2025

News

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy

Nagano, Japan / Melbourne, Australia– November 19, 2025 A-SEEDS Co., Ltd., a clinical-stage biotechnology company…

Josh DowningNovember 19, 2025

News

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region

October 1, 2025 — Cell Therapies Pty Ltd. (“Cell Therapies”) and Teijin Limited announced today…

Josh DowningSeptember 30, 2025

News

Cell Therapies and Viral Vector Manufacturing Facility (VVMF) enters strategic collaboration

Cell Therapies Pty Ltd (Cell Therapies) and Viral Vector Manufacturing Facility Pty. Ltd. (VVMF) have…

Cell TherapiesJuly 16, 2025

News

CTPL sign MoU with Xellera to Fast-Track CGT Access across APAC

Cell Therapies and Xellera Therapeutics Enter into a Strategic Partnership to Fast-Track Access to Cell…

Josh DowningApril 1, 2025

News

Cell Therapies to partner with Chimeric Therapeutics Ltd

Cell Therapies are pleased to announce that they are partnering with Chimeric Therapeutics to…

Josh DowningAugust 9, 2024

Resources

Technology Transfers for CGT products: Understanding what is needed for success

Transferring a cell and gene therapy (CGT) product from development to manufacturing involves a detailed…

Cell TherapiesJune 20, 2024

News

CTPL to be AdAlta’s preferred manufacturer of immunotherapies

Cell Therapies Pty Ltd to be preferred manufacturer of cellular immunotherapies Establishes key partnership to…

Cell TherapiesMay 12, 2024

Filter

The Australian Advantage

First patient treated in PLATYPS ‘in-house’ CAR T-cell therapy trial

Arovella IND Acceptance for iNKT Cell Therapy Platform

News and Resources

The latest news and insights from Cell Therapies

The Australian Advantage

First patient treated in PLATYPS ‘in-house’ CAR T-cell therapy trial

Arovella IND Acceptance for iNKT Cell Therapy Platform

ACTRIS Signs MoU with Cell Therapies Pty Ltd to Advance CDMO Capabilities for Cell and Gene Therapies

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region

Cell Therapies and Viral Vector Manufacturing Facility (VVMF) enters strategic collaboration

CTPL sign MoU with Xellera to Fast-Track CGT Access across APAC

Cell Therapies to partner with Chimeric Therapeutics Ltd

Technology Transfers for CGT products: Understanding what is needed for success

CTPL to be AdAlta’s preferred manufacturer of immunotherapies

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate